Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with an uncomplicated heart attack (either NSTEMI or STEMI type) according to current medical guidelines
- People who are 18 years of age or older at the time of giving consent
- People whose heart attack was treated with a procedure to open the blocked artery (such as a stent), and where the procedure was successful with good blood flow restored
- People who are able to understand the study information and are willing to sign and date a written consent form
Who may not be able to join:
- People whose heart attack was complicated by a cardiac arrest, either outside or inside the hospital
- People who experienced serious complications during their artery-opening procedure, such as a tear in an artery, a blocked side vessel, a severe allergic reaction, a stroke, or bleeding or injury at the site where instruments were inserted
- People who developed dangerous heart rhythm problems after the procedure, including fast or slow abnormal heart rhythms that persisted
- People with ongoing low blood pressure or signs that the body is not getting enough blood flow, requiring medicines to support the heart or blood vessels
- People with ongoing breathing problems or fluid in the lungs after the procedure
- People with ongoing reduced levels of consciousness, such as drowsiness or inability to be fully awoken
- People with a significant level of sudden kidney damage (as defined by a specific medical staging system, stages 2 or 3)
- People who are pregnant
- People who have other severely blocked heart arteries that also need treatment during the same hospital stay, which would prevent an early discharge
- People whose physical mobility or personal living situation would make an early discharge from hospital unsafe, as assessed by a care team
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Martin Reindl, MD, PhD, Medical University Innsbruck
Phone: +43 512 504 25665
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
MACE
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.